Association between metabolic score for insulin resistance and clinical outcomes: insights from the Tehran lipid and glucose study

Seyyed Saeed Tamehri Zadeh,Neda Cheraghloo,Soroush Masrouri,Farzad Esmaeili,Fereidoun Azizi,Farzad Hadaegh

DOI: https://doi.org/10.1186/s12986-024-00808-w

2024-06-14

Nutrition & Metabolism

Abstract:We aimed to assess the relationship between Metabolic Score for Insulin Resistance (METS-IR) and the incidence of coronary heart disease (CHD), stroke, mortality, diabetes, hypertension, and chronic kidney disease (CKD) in a population from the Middle East and North Africa (MENA) region.

nutrition & dietetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the relationship between the metabolic insulin resistance score (METS - IR) and coronary heart disease (CHD), stroke, all - cause mortality, diabetes, hypertension and chronic kidney disease (CKD), especially in the population in the Middle East and North Africa (MENA) region. The study aims to provide a scientific basis for health management and disease prevention in this region by analyzing the relationship between METS - IR and these clinical outcomes.

### Research Background
Insulin resistance (IR) is a key factor leading to metabolic diseases, such as diabetes, hypertension, chronic kidney disease (CKD) and cardiovascular disease (CVD). The incidence of these diseases is rising globally and has become a major cause of death and disability. Especially in the Middle East and North Africa (MENA) region, the age - standardized total prevalence of diabetes is the highest at the super - regional level.

### Research Objectives
The main objective of the study is to evaluate the relationship between METS - IR and coronary heart disease (CHD), stroke, all - cause mortality, diabetes, hypertension and chronic kidney disease (CKD), and to explore whether these relationships still exist in individuals without metabolic syndrome (METS) and/or diabetes.

### Research Methods
- **Research Design**: A prospective cohort study design was adopted, based on the data of the Tehran Lipid and Glucose Study (TLGS).
- **Research Subjects**: Participants aged ≥20 years were selected, with a total of 12,790 people.
- **Data Collection**: Baseline characteristics and follow - up data of participants were collected through questionnaires, laboratory tests and other methods.
- **Statistical Analysis**: The Cox proportional - hazards regression model was used to evaluate the relationship between METS - IR and different clinical outcomes.

### Main Findings
- **Coronary Heart Disease (CHD)**: Individuals in the highest quartile of METS - IR had a significantly increased risk of developing CHD (HR = 1.527, 95% CI: 1.208–1.930, P for trend = 0.001).
- **Diabetes**: Individuals in the highest quartile of METS - IR had a significantly increased risk of developing diabetes (HR = 3.277, 95% CI: 2.645–4.060, P for trend < 0.001).
- **Hypertension**: Individuals in the highest quartile of METS - IR had a significantly increased risk of developing hypertension (HR = 1.969, 95% CI: 1.752–2.214, P for trend < 0.001).
- **All - cause Mortality**: METS - IR had a U - shaped relationship with all - cause mortality, that is, individuals with lower and higher METS - IR had higher all - cause mortality.
- **Stroke**: There was no significant association between METS - IR and the occurrence of stroke.
- **Chronic Kidney Disease (CKD)**: There was no significant association between METS - IR and the occurrence of CKD.

### Conclusions
The increase in METS - IR level is significantly associated with an increased risk of coronary heart disease, diabetes and hypertension. Therefore, METS - IR can be used as a useful tool for evaluating the risk of these clinical outcomes. In addition, this association still exists even in individuals without metabolic syndrome and/or diabetes. This finding is of great significance for health management and disease prevention in the MENA region and other regions.